![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-021-09710-8/MediaObjects/10434_2021_9710_Fig1_HTML.png)
Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink
![Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy](https://pub.mdpi-res.com/cancers/cancers-14-03848/article_deploy/html/images/cancers-14-03848-g001.png?1660053841)
Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
![The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00276-y/MediaObjects/41523_2021_276_Fig1_HTML.png)
The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer
![The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub](https://www.pdffiller.com/preview/428/167/428167845/large.png)
The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub
![Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients - Bossuyt - 2020 - The Breast Journal - Wiley Online Library Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients - Bossuyt - 2020 - The Breast Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1aaed949-5c4f-462b-9551-ec8e88b8e698/tbj.v26.6.cover.jpg?trick=1680548507287)
Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients - Bossuyt - 2020 - The Breast Journal - Wiley Online Library
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610822002161-fx1.jpg)
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect
![Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2019/jco.2019.37.issue-26/jco.19.00647/20190827/images/large/jco.19.00647t4.jpeg)
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology
![A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology](https://www.thelancet.com/cms/attachment/fe468876-c413-4818-b918-0f871d688eda/gr1_lrg.jpg)
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology
![Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491730833X-gr2.jpg)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
![The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00366-x/MediaObjects/41523_2021_366_Fig1_HTML.png)
The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer
![Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology](https://mp.uscap.org/cms/asset/9ae860b0-dcac-4b6d-9b51-565655ad9366/gr1.jpg)
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)